Clinical Trials in Minneapolis

Showing 5961-5980 of 14,456 trials

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

NCT00984113

The purpose of the study is to determine the pharmacokinetics and safety of elinogrel and its metabolite in patients with mild, moderate, and severe renal impairment compared to healthy volunteers.

Renal Impairment

Portola Pharmaceuticals44 participantsStarted Sep 2009

Minneapolis, Minnesota, United States • Knoxville, Tennessee, United States

TERMINATEDPhase 27.4 miles

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

NCT04881448

This study is intended to investigate the usefulness of estimated glomerular filtration rate (eGFR) slopes derived from retrospective routine clinical practice data, compare those retrospective slopes with those generated in a prospective fashion and successively identify rapidly progressing chronic kidney disease (CKD) patients.

Chronic Kidney Disease

Boehringer Ingelheim223 participantsStarted Sep 2021

Huntsville, Alabama, United States • Victorville, California, United States • Victorville, California, United States +22 more locations

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

Find Trials by Condition in Minneapolis

A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Early Powered Mobility for Toddlers With Cerebral Palsy Using the Permobil® Explorer Mini and a Modified Ride-On Car

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

A Phase I Study of CX5461